Pediatric headache

Seminars in Pediatric Neurology

Volumn 17, Issue 4, 2010, Pages 224-229

  Lewis, Kara Stuart ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; DIHYDROERGOTAMINE MESILATE; DULOXETINE; ERGOTAMINE DERIVATIVE; FROVATRIPTAN; IBUPROFEN; NAPROXEN PLUS SUMATRIPTAN; NAPROXEN PLUS SUMATRIPTAN SUCCINATE; NARATRIPTAN; NORTRIPTYLINE; PLACEBO; PREGABALIN; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TIMOLOL; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; VERAPAMIL; ZOLMITRIPTAN;

ADOLESCENT; BEDTIME DOSAGE; BREATHING EXERCISE; CHILD; CLINICAL TRIAL; CONSTIPATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HOT FLUSH; HUMAN; INCREASED APPETITE; MENSTRUAL MIGRAINE; MIGRAINE; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; RASH; RELAXATION TRAINING; REVIEW; SKIN BURNING SENSATION; SKIN TINGLING; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; AGE FACTORS; ANALGESICS; CHILD; HEADACHE; HUMANS; MIGRAINE DISORDERS;

EID: 78650297563     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.10.004     Document Type: Review

References (20)

1. Silberstein S.D. Migraine pathophysiology and its clinical implications. Cephalalgia 2004, 24:1045-1048.
2. Cutrer F.M. Pathophysiology of migraine. Semin Neurol 2010, 30:120-130.
3. Villalon C.M., Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 2009, 124:309-323.
4. Hohoff C., Marziniak M., Lesch K.P., et al. An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia 2007, 27:177-181.
5. Linder S.L. Treatment of childhood headache with dihydroergotamine mesylate. Headache 1994, 34:578-580.
6. Callenbach P.M., Pels L.P., Mulder P.G., et al. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children. Eur J Paediatr Neurol 2007, 11:325-330.
7. Linder S.L., Mathew N.T., Cady R.K., et al. Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial. Headache 2008, 48:1326-1336.
8. Ho T.W., Ferrari M.D., Dodick D.W., et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial. Lancet 2008, 372:2115-2123.
9. De Felice M., Ossipov M.H., Wang R., et al. Triptan-induced latent sensitization: A possible basis for medication overuse headache. Ann Neurol 2010, 67:325-337.
10. Edvinsson L., Linde M. New drugs in migraine treatment and prophylaxis: Telgagepant and topiramate. Lancet 2010, 376:645-655.
11. Lewis D.W., Diamond S., Scott D., et al. Prophylactic treatment of pediatric migraine. Headache 2004, 44:230-237.
12. Eiland L.S., Jenkins L.S., Durham S.H. Pediatric migraine: Pharmacologic agents for prophylaxis. Ann Pharmacother 2007, 41:1181-1190.
13. Bidabadi E., Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatr Drugs 2010, 12:269-275.
14. Winner P., Pearlman E.M., Linder S.L., et al. Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial. Headache 2005, 45:1304-1312.
15. Lakshmi C.V., Singhi P., Malhi P., et al. Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial. J Child Neurol 2007, 22:829-835.
16. Cruz M.J., Valencia I., Legido A., et al. Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol 2009, 41:167-170.
17. Unalp A., Uran N., Ozturk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol 2008, 23:1377-1381.
18. Cuvellier J.C., Riquet A., Vallee L. Antiepileptic drugs in pediatric migraine. Arch Pediatr 2008, 15:1693-1699.
19. Cuvellier J.C. Antiepileptic drugs for the prevention of pediatric migraine. Rev Neurol 2009, 165:1002-1009.
20. Lewis D., Ashwal S., Hershey A., et al. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004, 63:2215-2224.